[Federal Register Volume 76, Number 77 (Thursday, April 21, 2011)]
[Rules and Regulations]
[Page 22322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-9649]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 866

[Docket No. FDA-2010-N-0026]


Medical Devices; Immunology and Microbiology Devices; 
Classification of Ovarian Adnexal Mass Assessment Score Test System; 
Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of March 23, 2011 (76 FR 
16292). The document announced the classifying of ovarian adnexal mass 
assessment score test system into class II (special controls). The 
document was published with an incorrect docket number. This document 
corrects that error.

DATES: Effective: April 22, 2011.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, 
Planning and Budget, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2011-6620, appearing on page 
16292, in the Federal Register of Wednesday, March 23, 2011, the 
following correction is made:
    1. On page 16292, in the first column, in the Docket No. heading, 
``[Docket No. FDA-2011-N-0026]'' is corrected to read ``[Docket No. 
FDA-2010-N-0026].''

    Dated: April 13, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-9649 Filed 4-20-11; 8:45 am]
BILLING CODE 4160-01-P